Trial Profile
Qualitative and quantitative effect of fixed-dose combination of insulin-degludec/liraglutide versus non-fixed administration of degludec and liraglutide in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Insulin degludec/liraglutide (Primary) ; Insulin degludec; Liraglutide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 11 Jun 2019 Results examining the effect of the IDegLira on the glycemic control and the cardiometabolic risk factors compared to the non-fixed adiministration of degludec and liraglutide presented at the 79th Annual Scientific Sessions of the American Diabetes Association
- 20 Jul 2018 New trial record
- 26 Jun 2018 Results presented at the 78th Annual Scientific Sessions of the American Diabetes Association